CO-D Therapeutics, Inc. — Form D/A
CO-D Therapeutics, Inc. of MADISON, WI, a company, filed a Form D amendment with the SEC on 2018-11-09. The offering totals $528K, of which $428K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-11-09
- Form: D/A
- Accession: 0000897069-18-000596
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $528K
- Amount sold: $428K
- Remaining: $100K
- Investors: 16
- Date of first sale: 2015-12-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-255775
Issuer
- Name: CO-D Therapeutics, Inc.
- CIK: 0001664124
- Entity type: Corporation
- Jurisdiction: WISCONSIN
- Incorporated: 2012
- Address: 316 West Washington Avenue, MADISON, WI, 53703
- Phone: (608) 358-9655
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| J. Patrick Genn | Director | Madison, WI |
| ALEX S KIM | Director | ROCKVILLE, MD |
| Kevin R Kozak | Director | Madison, WI |
| Glen S Kwon | Director | Madison, WI |
| Paul V Radspinner | Director | Madison, WI |
| Abdalla A Saad | Director | Madison, WI |
| Kevin R Kozak | Executive Officer | Madison, WI |
| Glen S Kwon | Executive Officer | Madison, WI |
| Abdalla A Saad | Executive Officer | Madison, WI |
| Glen S Kwon | Promoter | Madison, WI |
| Kevin R Kozak | Promoter | Madison, WI |
| Abdalla Saad | Director | Madison, WI |
| Abdalla Saad | Executive Officer | Madison, WI |
| Abdalla Saad | Promoter | Madison, WI |
Other filings by this issuer (1)
More